Key result
Inflammatory and infectious pathways link AF and Alzheimer disease as shared therapeutic targets.
Why the study?
The exact mechanisms linking atrial fibrillation and Alzheimer disease remain unknown, though inflammatory processes and infectious agents have recently been implicated in both conditions.
Answers are grounded in this paper and cite their sources.
This review highlights systemic inflammation and infection as common pathways between atrial fibrillation and Alzheimer's disease, suggesting a basis for potential shared pharmacological strategies.
Atrial fibrillation (AF) is one of the most prevalent forms of arrhythmia that carries an increased risk of stroke which, in turn, is strongly associated with cognitive decline. The majority of dementia cases are caused by Alzheimer's disease (AD) with obscure pathogenesis. While the exact mechanisms are unknown, the role of inflammatory processes and infectious agents have recently been implicated in both AD and AF, suggesting a common link between these maladies. Here, we present the main shared pathways underlying arrhythmia and memory loss. The overlapping predictive biomarkers and emerging joint pharmacological approaches are also discussed.
No takes yet. Share an insight, caveat, or question.
Martins et al. (2020) conducted a review in Atrial Fibrillation and Alzheimer's Disease. Inflammatory and infectious processes was evaluated. Inflammatory processes and infectious agents serve as shared pathophysiological links connecting atrial fibrillation and Alzheimer's disease, offering potential joint therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: